SkinVive: The First FDA-Approved Injectable Moisturizer
SKIN

SkinVive: The First FDA-Approved Injectable Moisturizer

By Soo · · Allergan Aesthetics / FDA
KO | EN

The approach to skin hydration is evolving. From applying moisture to the surface toward placing it directly inside the skin. SkinVive, the first FDA-approved injectable skin booster, represents this shift.

A Different Approach to Moisturizing

SkinVive by JUVÉDERM delivers hyaluronic acid in microdroplet form into the upper dermis. Unlike conventional HA fillers that add volume, SkinVive uses a water-like formulation that disperses between skin tissues, drawing in and holding moisture. The target is not volume but skin texture, hydration, and radiance.

Its distinction is official: the FDA approved it specifically for improving cheek skin smoothness, making it the first injectable skin booster with this indication.

What Clinical Trials Showed

Patient evaluations at 3 months post-treatment tell a specific story. 84% reported improved overall skin health, 78% noticed better hydration, 74% saw improved radiance, and 79% said their skin looked more refreshed. Satisfaction persisted through the 6-month mark.

Duration of effect ranges from 6 to 9 months, with some cases extending up to a year. Individual variation depends on baseline skin condition and lifestyle factors.

The Practical Experience

The procedure involves microdroplet injections to both cheeks, completed in roughly 15 to 20 minutes. With topical anesthesia, pain is minimal. Mild swelling or bruising may appear immediately after but typically clears within a day or two. Patients return to normal activities immediately.

The Growing Skin Booster Category

Europe and Asia have had similar skin boosters like Profhilo and Juvelook for years, but SkinVive was the product that officially opened this category in the U.S. market. The 2026 injectable landscape shows a clear expansion from “filling” toward “skin quality improvement.”

Where topical moisturizers slow water evaporation from the skin surface, injectable moisturizers create a hydration reservoir directly in the dermis. Treatment costs typically range from $300 to $600 per session.

Frequently Asked Questions

How is SkinVive different from dermal fillers? Traditional HA fillers like JUVÉDERM and Restylane focus on adding volume. SkinVive targets skin texture instead. Its water-like formula is injected as microdroplets into the upper dermis, attracting moisture and improving smoothness without adding volume.

What does the treatment involve? Microdroplet injections are administered to both cheeks, taking about 15~20 minutes. With topical numbing cream, discomfort is minimal. Mild swelling or bruising may occur but typically resolves within 1~2 days.

How long do results last? Clinical data shows 6~9 months of improvement, with some cases extending up to a year depending on skin condition and lifestyle. Maintenance treatments every 6~9 months can sustain the effect.